Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines

Factor H binding protein (fHbp) is a major protective antigen in 4C-MenB (Bexsero®) and Trumenba®, two serogroup B meningococcal vaccines, wherein expression level is a determinant of protection. Examination of promoter-containing intergenic region (IGR) sequences indicated that nine fHbp IGR alleles covered 92% of 1,032 invasive meningococcal strains with variant 1 fHbp alleles. Relative expression values for fHbp were determined for 79 meningococcal isolates covering ten IGR alleles by quantitative reverse transcriptase polymerase chain reaction (qRT PCR). Derivation of expression clusters of IGR sequences by linear regression identified five expression clusters with five nucleotides and one insertion showing statistically associations with differences in expression level. Sequence analysis of 273 isolates examined by the Meningococcal Antigen Typing Scheme, a sandwich ELISA, found that coverage depended on the IGR expression cluster and vaccine peptide homology combination. Specific fHbp peptide-IGR expression cluster combinations were designated as ‘at risk’ for coverage by 4C-MenB and were detected in multiple invasive meningococcal disease cases confirmed by PCR alone and occurring in partially-vaccinated infants. We conclude that sequence-based analysis of IGR sequences is informative for assessing protein expression and has utility for culture-independent assessments of strain coverage by protein-based vaccines.

[1]  M. Pizza,et al.  Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. , 2017, The Lancet. Infectious diseases.

[2]  H. Lavender,et al.  Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame , 2016, PLoS pathogens.

[3]  P. Balmer,et al.  Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®) , 2016, Postgraduate medicine.

[4]  K. Jansen,et al.  Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution. , 2016, The Journal of infection.

[5]  R. Rappuoli,et al.  Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined , 2016, Proceedings of the National Academy of Sciences.

[6]  J. Morrissey,et al.  Men B: lack of coverage or vaccine failure? , 2016, The Lancet.

[7]  V. Saliba,et al.  The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme--New challenges for public health. , 2015, The Journal of infection.

[8]  J. Bray,et al.  Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study , 2015, The Lancet. Infectious diseases.

[9]  D. Medini,et al.  Bexsero® chronicle , 2014, Pathogens and global health.

[10]  A. Deghmane,et al.  Genetic Diversity and Levels of Expression of Factor H Binding Protein among Carriage Isolates of Neisseria meningitidis , 2014, PloS one.

[11]  R. Borrow,et al.  Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens , 2014, PloS one.

[12]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[13]  S. Ladhani,et al.  Added value of PCR-testing for confirmation of invasive meningococcal disease in England. , 2013, The Journal of infection.

[14]  R. Rappuoli,et al.  Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. , 2013, The Lancet. Infectious diseases.

[15]  C. Genco,et al.  Fur-Mediated Global Regulatory Circuits in Pathogenic Neisseria Species , 2012, Journal of bacteriology.

[16]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[17]  M. Maiden,et al.  The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes , 2012, Microbiology.

[18]  Martin C. J. Maiden,et al.  BIGSdb: Scalable analysis of bacterial genome variation at the population level , 2010, BMC Bioinformatics.

[19]  R. Rappuoli,et al.  Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines , 2010, Proceedings of the National Academy of Sciences.

[20]  L. Harrison,et al.  Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates. , 2010, Vaccine.

[21]  V. Scarlato,et al.  Expression of Factor H Binding Protein of Meningococcus Responds to Oxygen Limitation through a Dedicated FNR-Regulated Promoter , 2009, Journal of bacteriology.

[22]  D. Granoff,et al.  The modular architecture of meningococcal factor H-binding protein. , 2009, Microbiology.

[23]  R. Rappuoli,et al.  Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37 , 2008, Infection and Immunity.

[24]  S. Ram,et al.  Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. , 2008, The Journal of infectious diseases.

[25]  David H Perlman,et al.  The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance , 2006, The Journal of Immunology.

[26]  R. Rappuoli,et al.  Effect of Neisseria meningitidis Fur Mutations on Global Control of Gene Transcription , 2006, Journal of bacteriology.

[27]  Jeannette Adu-Bobie,et al.  Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870 , 2003, The Journal of experimental medicine.

[28]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .